North Star Asset Management’s abrdn Life Sciences Investors HQL Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2018
Q3 | – | Sell |
-10,130
| Closed | -$190K | – | 295 |
|
2018
Q2 | $190K | Sell |
10,130
-3,247
| -24% | -$60.9K | 0.02% | 281 |
|
2018
Q1 | $257K | Hold |
13,377
| – | – | 0.02% | 248 |
|
2017
Q4 | $263K | Hold |
13,377
| – | – | 0.02% | 250 |
|
2017
Q3 | $287K | Hold |
13,377
| – | – | 0.03% | 214 |
|
2017
Q2 | $279K | Hold |
13,377
| – | – | 0.03% | 213 |
|
2017
Q1 | $259K | Hold |
13,377
| – | – | 0.03% | 210 |
|
2016
Q4 | $227K | Hold |
13,377
| – | – | 0.03% | 217 |
|
2016
Q3 | $251K | Sell |
13,377
-2,150
| -14% | -$40.3K | 0.03% | 209 |
|
2016
Q2 | $267K | Sell |
15,527
-265
| -2% | -$4.56K | 0.03% | 201 |
|
2016
Q1 | $283K | Sell |
15,792
-1
| -0% | -$18 | 0.03% | 197 |
|
2015
Q4 | $373K | Buy |
15,793
+118
| +0.8% | +$2.79K | 0.04% | 187 |
|
2015
Q3 | $353K | Sell |
15,675
-868
| -5% | -$19.5K | 0.04% | 192 |
|
2015
Q2 | $467K | Buy |
16,543
+128
| +0.8% | +$3.61K | 0.05% | 186 |
|
2015
Q1 | $453K | Sell |
16,415
-350
| -2% | -$9.66K | 0.05% | 186 |
|
2014
Q4 | $417K | Sell |
16,765
-1,211
| -7% | -$30.1K | 0.05% | 188 |
|
2014
Q3 | $397K | Sell |
17,976
-8,065
| -31% | -$178K | 0.05% | 192 |
|
2014
Q2 | $541K | Buy |
26,041
+7,631
| +41% | +$159K | 0.06% | 172 |
|
2014
Q1 | $400K | Sell |
18,410
-314
| -2% | -$6.82K | 0.05% | 186 |
|
2013
Q4 | $383K | Hold |
18,724
| – | – | 0.05% | 186 |
|
2013
Q3 | $360K | Sell |
18,724
-4,601
| -20% | -$88.5K | 0.05% | 188 |
|
2013
Q2 | $417K | Buy |
+23,325
| New | +$417K | 0.06% | 175 |
|